Editorial
doi: 10.1093/annonc/mdz043.
HER2: defining a Neu target in non-small-cell lung cancer
Affiliations
- PMID: 30715217
- DOI: 10.1093/annonc/mdz043
Item in Clipboard
Editorial
HER2: defining a Neu target in non-small-cell lung cancer
Ann Oncol.
.
Free article
No abstract available
Comment on
-
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.Ann Oncol. 2019 Mar 1;30(3):447-455. doi: 10.1093/annonc/mdy542. Ann Oncol. 2019. PMID: 30596880 Free PMC article. Clinical Trial.
Similar articles
-
The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy.Pneumonol Alergol Pol. 2013;81(4):294-7. Pneumonol Alergol Pol. 2013. PMID: 23744164
-
Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.Cancer Lett. 2009 Aug 28;281(2):134-43. doi: 10.1016/j.canlet.2009.02.036. Epub 2009 Mar 31. Cancer Lett. 2009. PMID: 19339104
-
Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.Clin Lung Cancer. 2006 Mar;7(5):332-7. doi: 10.3816/clc.2006.n.015. Clin Lung Cancer. 2006. PMID: 16640805
-
HER2 and lung cancer.Expert Rev Anticancer Ther. 2013 Oct;13(10):1219-28. doi: 10.1586/14737140.2013.846830. Expert Rev Anticancer Ther. 2013. PMID: 24134423 Review.
-
Targeting HER2 in the treatment of non-small cell lung cancer.Lung Cancer. 2015 Mar;87(3):220-5. doi: 10.1016/j.lungcan.2014.12.018. Epub 2015 Jan 8. Lung Cancer. 2015. PMID: 25601485 Review.
Cited by
-
Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer.Front Oncol. 2021 May 21;11:632256. doi: 10.3389/fonc.2021.632256. eCollection 2021. Front Oncol. 2021. PMID: 34094913 Free PMC article. Review.
-
Recent advances in non-small cell lung cancer targeted therapy; an update review.Cancer Cell Int. 2023 Aug 11;23(1):162. doi: 10.1186/s12935-023-02990-y. Cancer Cell Int. 2023. PMID: 37568193 Free PMC article. Review.
-
(-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.Nutrients. 2020 Jun 11;12(6):1749. doi: 10.3390/nu12061749. Nutrients. 2020. PMID: 32545325 Free PMC article.
-
Pyrotinib as a salvage treatment for patients with HER-2 positive advanced lung adenocarcinoma after the progression of afatinib treatment.Clin Transl Oncol. 2024 Dec;26(12):3050-3057. doi: 10.1007/s12094-024-03482-9. Epub 2024 May 25. Clin Transl Oncol. 2024. PMID: 38795256
-
Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.Front Oncol. 2021 Dec 1;11:750657. doi: 10.3389/fonc.2021.750657. eCollection 2021. Front Oncol. 2021. PMID: 34926258 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
